Synthesis of a Long Acting HIV Protease Inhibitor via Metal or Enzymatic Reduction of the Appropriate Chloro Ketone and Selective Zinc Enolate Condensation with an Amino Epoxide

被引:5
作者
Houpis, Ioannis N. [1 ]
Liu, Renmao [2 ]
Liu, Lin [2 ]
Wang, Yanfei [2 ]
Dong, Nengfa [2 ]
Zhao, Xiangan [2 ]
Zhang, Yan [2 ]
Xiao, Tingting [2 ]
Wang, Youchu [2 ]
Depre, Dominique [2 ]
Nettekoven, Ulrike [3 ]
Vogel, Michael [4 ]
Wilson, Rob [4 ]
Collier, Steve [4 ]
机构
[1] Janssen Pharmaceut, API Development, B-2340 Beerse, Belgium
[2] STA Pharmaceut, Shanghai 200131, Peoples R China
[3] Solvias AG, CH-4303 Kaiseraugst, Switzerland
[4] Codexis, Redwood City, CA 94063 USA
关键词
asymmetric ketone reduction; enzymatic ketone reduction; long acting HIV protease inhibitors; zinc enolate addition to epoxides; ALPHA-CHLOROKETONES; POTENT; ISOSTERES; DESIGN;
D O I
10.1002/adsc.201300074
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
This paper describes a new convergent approach to the synthesis of an HIV protease inhibitor which was designed to be suitable in long acting formulations. Unique features in the synthesis include an asymmetric hydrogenation as well as enzymatic reduction of a key chloro ketone intermediate, to set the threo stereochemistry in the corresponding epoxide and the diastereoselective coupling of the latter with the zinc enolate of a suitable functionalized amide derivative.
引用
收藏
页码:1829 / 1839
页数:11
相关论文
共 28 条
[1]  
Ala PJ, 2005, CRC ENZYM INHIB SER, P268
[2]   HIGHLY DIASTEREOSELECTIVE REACTION OF A CHIRAL, NON-RACEMIC AMIDE ENOLATE WITH (S)-GLYCIDYL TOSYLATE - SYNTHESIS OF THE ORALLY-ACTIVE HIV-1 PROTEASE INHIBITOR L-735,524 [J].
ASKIN, D ;
ENG, KK ;
ROSSEN, K ;
PURICK, RM ;
WELLS, KM ;
VOLANTE, RP ;
REIDER, PJ .
TETRAHEDRON LETTERS, 1994, 35 (05) :673-676
[3]   HIGHLY DIASTEREOSELECTIVE SYNTHESIS OF THREO OR ERYTHRO AMINOALKYL EPOXIDES FROM ALPHA-AMINO-ACIDS [J].
BARLUENGA, J ;
BARAGANA, B ;
CONCELLON, JM .
JOURNAL OF ORGANIC CHEMISTRY, 1995, 60 (21) :6696-6699
[4]   New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors:: Candidates for clinical development [J].
Bold, G ;
Fässler, A ;
Capraro, HG ;
Cozens, R ;
Klimkait, T ;
Lazdins, J ;
Mestan, J ;
Poncioni, B ;
Rösel, J ;
Stover, D ;
Tintelnot-Blomley, M ;
Acemoglu, F ;
Beck, W ;
Boss, E ;
Eschbach, M ;
Hürlimann, T ;
Masso, E ;
Roussel, S ;
Ucci-Stoll, K ;
Wyss, D ;
Lang, R .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) :3387-3401
[5]   Synthesis of potent and orally active HIV-protease inhibitors [J].
Capraro, HG ;
Bold, G ;
Fassler, A ;
Cozens, R ;
Klimkait, T ;
Lazdins, J ;
Poncioni, B ;
Rosel, JL ;
Stover, D ;
Lang, M .
ARCHIV DER PHARMAZIE, 1996, 329 (06) :273-278
[6]   A practical method for the preparation of alpha'-chloroketones of N-carbamate protected-alpha-aminoacids [J].
Chen, P ;
Cheng, PTW ;
Spergel, SH ;
Zahler, R ;
Wang, XB ;
Thottathil, J ;
Barrish, JC ;
Polniaszek, RP .
TETRAHEDRON LETTERS, 1997, 38 (18) :3175-3178
[7]   SYNTHESIS AND REDUCTION OF ALPHA-AMINO KETONES DERIVED FROM LEUCINE [J].
DUFOUR, MN ;
JOUIN, P ;
PONCET, J ;
PANTALONI, A ;
CASTRO, B .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1986, (11) :1895-1899
[8]   AN EFFICIENT SYNTHESIS OF HYDROXYETHYLENE DIPEPTIDE ISOSTERES - THE CORE UNIT OF POTENT HIV-1 PROTEASE INHIBITORS [J].
GHOSH, AK ;
MCKEE, SP ;
THOMPSON, WJ .
JOURNAL OF ORGANIC CHEMISTRY, 1991, 56 (23) :6500-6503
[9]  
Gohring W, 1996, CHIMIA, V50, P532
[10]   Asymmetric transfer hydrogenation of α-aminoalkyl α′-chloromethyl ketones with chiral Rh complexes [J].
Hamada, T ;
Torii, T ;
Onishi, T ;
Izawa, K ;
Ikariya, T .
JOURNAL OF ORGANIC CHEMISTRY, 2004, 69 (21) :7391-7394